| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.26 | 4e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |